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ABSTRACT
Methylation of lysine 9 (K9) in the N-terminus tail
of histone H3 (H3) in chromatin is associated with
transcriptionally silenced genes and is mediated by
histone methyltransferases. Murine G9a is a 1263
amino acid H3-K9 methyltransferase that possesses
characteristic SET domain and ANK repeats. In this
paper, we have used a series of green fluorescent
protein-tagged deletion constructs to identify two
nuclear localization signals (NLS), the first NLS
embedded between amino acids 24 and 109 and the
second between amino acids 394 and 401 of murine
G9a. Our data show that both long and short G9a
isoforms were capable of entering the nucleus to
methylate chromatin. Full-length or N-terminus-
deleted G9a isoforms were also catalytically active
enzymesthatmethylatedrecombinantH3orsynthetic
peptides representing the N-terminus tail of H3. In
vitromethylationreactionsusingN-terminus tailpep-
tides resulted in tri-methylation of K9 that remained
processive, even in G9a enzymes that lacked an N-
terminus region by deletion. Co-expression of G9a
and H3 resulted in di- and tri-methylation of H3-K9,
while siRNA-mediated knockdown of G9a in HeLa
cells resulted in reduction of global H3-K9 di-
and tri-methylation. A recombinant deletion mutant
enzyme fused with maltose-binding protein (MBP-
G9aD634) was used for steady-state kinetic analysis
with various substrates and was compared with full-
length G9a (G9aFL). Turnover numbers of MBP-
G9aD634forvarioussubstrateswas 3-foldlesscom-
pared with G9aFL, while their Michaelis constants
(Km) for recombinant H3 were similar. The Km
AdoMet
for MBP-G9aD634 was  2.3–2.65 mM with various
substrates. Catalytic efficiencies (kcat/Km) for both
MBP-G9aD634 and G9aFL were similar, suggesting
that the N-terminus is not essential for catalysis.
Furthermore, mutation of conserved amino acids
R1097A, W1103A, Y1120A, Y1138A and R1162A, or
the metal binding C1168A in the catalytic region,
resulted in catalytically impaired enzymes, thereby
confirming the involvement of the C-terminus of
G9a in catalysis. Thus, distinct domains modulate
nuclear targeting and catalytic functions of G9a.
INTRODUCTION
In eukaryotic nuclei, DNA associates with proteins to generate
the heritable genetic information contained within chro-
matin. Transcriptionally active regions of the genome reside
in euchromatin, whereas inactive regions reside in heterochro-
matin.Regulationof euchromaticandheterochromaticregions
forms the basis of epigenetic gene expression control (1) and
properchromosomecondensationduringmeiosis(2,3).Altera-
tions in chromatin structure have a vital role in changing the
gene expression. Many alterations are targeted by speciﬁc
chromatin remodeling complexes (4) and/or by DNA modi-
ﬁcation enzymes (5) directed at nucleosomes, the fundamental
structural unit of chromatin. Nucleosomes are composed of
146 bp of DNA wrapped around an octamer of core histone
proteins H2A, H2B, H3 and H4 (6) that are often modiﬁed
at speciﬁc amino acid residues (7). These post-translational
modiﬁcations include acetylation, phosphorylation, poly-
ADP-ribosylation, ubiquitination and methylation (8). Such
modiﬁcations have major roles in regulating gene transcrip-
tion, heterochromatin formation, X chromosome inactivation,
DNA replication, DNA repair and cellular memory (8–13).
Histones are small basic proteins with globular core
domains and ﬂexible, charged N-terminus regions that pro-
trude out of the nucleosome core leaving them susceptible to
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doi:10.1093/nar/gki635post-translational modiﬁcations. In histone H3, ﬁve lysine
residues (K4, K9, K27, K36 and K79) and K20 in histone
H4 may become methylated. Of the different site-speciﬁc
H3 methylating sites, K9 methylation is well known for its
role in heterochromatin formation, transcriptional silencing,
X chromosome inactivation and DNA methylation (14).
Several enzymes for K9 methylation have been puriﬁed and
studied. The ﬁrst was Suv39h1, cloned and expressed by
Jenuwein and co-workers (15). Another close relative,
Suv39h2, was also cloned and characterized (16). Both
Suv39h1 and h2 contain SET [(Su(var), Enhancer of zeste,
Trithorax] domains and their catalytic activities are dependent
on this domain. The SET domain has a unique structure (17),
rich in b-sheets, with each small sheet containing only a few
strands. Although these K9 methyltransferases use AdoMet as
a cofactor, no similarities with the canonical a/b AdoMet-
dependent methyltransferases have been described previously
(18). Furthermore, both Suv39h1 and h2 contain a chromo
domain that is considered a chromatin regulatory motif. The
SUV39H family of proteins contributes to the organization of
repressivechromatinregions,suchasthecentromeres(19),and
is co-localized with heterochromatin-binding protein 1 (HP1)
in heterochromatic regions of the mammalian genome (20).
Apart from the SUV39H family enzymes, three additional
mammalian H3-K9 methyltransferases—G9a, ESET/
SETDB1 and Eu-HMTase 1—have been reported previously
(21–23).UnliketheSUV39H family,theseproteinsparticipate
in H3-K9 methylation in euchromatic regions of the genome
(24). Along with enzymatic catalysis, Eu-HMTase 1 also asso-
ciates with E2F-6, Mga and Max proteins and may be involved
in the silencing of E2F and Myc responsive genes in quiescent
cells (23). The fact that multiple histone methyltransferases
are capable of the same target lysine methylation raises the
issue of redundancy in their functions. Targeted inactivation
of G9a resulted in growth retardation and early embryonic
lethality, suggesting that G9a-mediated H3-K9 methylation
in euchromatic regions is essential for development (25)
and cannot be compensated for by the other three known
K9 methyltransferases. It is possible that different histone
methyltransferases methylate K9 at different times during
the cell-cycle or development. Another H3-K9 methyltrans-
ferase, ESET, participates in early mammalian development
(26). Xin et al. (27) also demonstrated that H3-K9 methylation
of the Prader-Willi syndrome imprinting center is reduced in
G9a-null mouse ES cells, and maintenance of CpG methyla-
tion in the Prader-Willi syndrome imprinting center requires
G9a function, bringing two global epigenetic modiﬁers, DNA
and histone methylation, together. Furthermore, G9a is a tran-
scriptional repressor of PRDI-BF1, a DNA-binding protein
involved in post-induction repression of interferon-b gene
transcription in response to viral infections (28).
G9a is expressed ubiquitously and was originally mapped to
the class III region of the major histocompatibility complex
locus (29). Mouse G9a is 1263 amino acids long. The amino
halfofG9ahasverylittlesimilaritywithanyconservedprotein
domain. However, the carboxy half has homology with ANK
(ankyrin) repeats, and contains preSET and SET domains. The
SET domains are conserved in chromatin-modifying enzymes
(22) that include histone methyltransferases (30),whichrecog-
nize histone tails and modify speciﬁc lysine residues (31).
A second distinguishing feature of G9a is the presence of
severalANKrepeatsimplicatedinprotein–proteininteractions
in very diverse protein families. G9a is also homologous to
human SUV39H1 and yeast Clr4 family proteins.
Although G9a is crucial for transcriptional silencing and
development, very little is known about its functional domains
and its association with chromatin. Furthermore, there is
emerging evidence for chromatin modifying enzymes, such
as histone methyltransferases, in establishing and maintaining
gene silencing either alone (32) or in cooperation with DNA
methyltransferases (33). Here, we have evaluated the func-
tional domains of mouse G9a for nuclear localization features
and the minimal elements required for catalysis. The func-
tional signiﬁcance of conserved C-terminus amino acids for
enzymatic activity was also determined.
MATERIALS AND METHODS
Bacterial strains
All protein expression constructs were either transformed
into ER2566 [New England Biolabs (NEB)] or BL21DE3
(Invitrogen) Escherichia coli strains for protein puriﬁcation.
All other constructs were propagated in ER2502 E.coli
strain (NEB).
Green fluorescent protein (GFP) fusion gene constructs
and cytochemical detection of fusion proteins
All PCR ampliﬁcations were performed using Vent DNA
Polymerase (NEB), and ligations were performed using Quick
ligation kits (NEB).G9a full-length (G9aFL) and various dele-
tion mutants were constructed with the pEGFPc2 back bone
vector (BD Biosciences). The G9aFL construct (pZKmG9a)
was based on the GenBank sequence accession no. AB077210
that was used as a template for PCR gene ampliﬁcation to
makevariousGFPfusionconstructs.Thelistofprimersusedis
available upon request.
For detailed analysis of the second conserved nuclear loc-
alization signal (NLS), PCR ampliﬁcation and cloning was
performed with forward primer GCCGAATTCAGAAAACG-
GCGGAAACGAGAGandreverse primerACGCGTCGACT-
CAGTAGACACAGCCACCTAACTGCAC. PCR products
were cloned into EcoRI and SalI sites. Annealing synthetic
oligonucleotides and cloning into the pEGFPc2vector resulted
in G9aNLS2, G9aNLS-KP, G9aNLS-KD and G9aNLS-mKD
constructs. All constructs were sequenced and conﬁrmed.
Forimmunocytochemistry,COS-7 and HeLa cells were cul-
tured on cover slips and transfected with a mixture of plasmid
DNAandFuGENE6(Roche)ataratioof1:3mg/ml.Forty-eight
hourspost-transfection,thecellswereﬁxedwith4%paraform-
aldehyde, washed once with 1· phosphate-buffered saline
(PBS) (pH 7.4) and permeabilized with 0.2% Triton X-100.
After three washes with PBS, nuclear staining was performed
with Hoechst 33342 dye (Molecular Probes). GFP constructs
were visualized using a ﬂuorescence microscope with either a
63· or a 100·/1.4 oil Zeiss objective lens at 488 nm.
Wild-type and mutant histone H3 constructs
An intein vector, pTYB2 (NEB), was used for cloning
and puriﬁcation of recombinant human histone H3 protein
and its mutants. The histone H3 was PCR ampliﬁed
from human genomic DNA using the forward primer
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reverse primer CCGCTCGAGCCCGGGTGCCCTCTCTC-
CGCGAATGCGGC. The PCR ampliﬁed product was cloned
into pCR2.1-TOPO (Invitrogen) and conﬁrmed by restriction
digestion and DNA sequencing. The histone H3 insert was
recovered from the pCR2.1-TOPO vector by restriction diges-
tion with NdeI and SmaI, followed by ligation into the pTYB2
vector digested with NdeI and SmaI, and then transformed
into E.coli ER2566. This clone is pTYB2H3wt.
For PCR ampliﬁcation of histone H3-K4A, H3-K9A and
H3-K4AK9A mutants, the plasmid pCR2.1-TOPO::H3 was
used as a template. pTYB2::H3-K9A and pTYB2::H3-
K4AK9A were used to amplify NdeI/AgeI ( 100 bp)
fragments of histone H3 mutants, H3-K9AK27A and
H3-K4AK9AK27A, respectively. For this, the pCR2.1-
TOPO::H3 vector was digested with NdeI and AgeI and lig-
ated with the  100 bp PCR products digested with NdeI/AgeI.
The inserts H3-K9AK27A and H3-K4AK9AK27A were
excised from pCR2.1-TOPO::H3-K9AK27A and pCR2.1-
TOPO::H3-K4AK9AK27A by restriction digestion with NdeI
and AgeI and cloned into pTYB2. H3 wild-type, H3-K4A,
H3-K9A and H3-K4AK9A had the same reverse primer; how-
ever, the forward primers were different. For H3-K4A:
GGAATTCCATATGGCACGCACGGCGCAAACAGCTC;
for H3-K9A GGAATTCCATATGGCACGCACGAAGCA-
AACAGCTCGTGCGTCCACTGGC; and for H3-K4AK9A:
GAATTCCATATGGCACGCACGGCGCAAACAGCTCGT-
GCGTCCACTGGC.
The H3-K9AK27A forward primer is the same as the
wild-type H3 primer, whereas the reverse primer is CACG-
CCACCGGTGGCTGGCGCGCTTGCGCGAGCC. For this
construct, pTYB2H3-K9A was used as a template. For
H3-K4AK9AK27A, the reverse primer was the same as for
H3-K9AK27A, whereas the forward primer was the same as
for H3-K4A.
Purification of histone H3 from E.coli
ER2566 cells containing the histone H3 expression constructs
were grown in Luria–Bertani medium with 100 mg/l ampicil-
lin followed by 0.5 mM isopropyl-b-D-thiogalactopyranoside
(IPTG) induction. The cells were lysed in 50 mM Tris–HCl,
pH 7.8, 500 mM NaCl, 1 mM EDTA and 0.01% Triton X-100
with a protease inhibitor cocktail (Sigma) and 0.7 mg/ml
phenylmethlysulfonyl ﬂuoride (PMSF). Cleared lysates
were incubated with chitin beads and were washed with
lysis buffer. The H3 protein was cleaved from chitin beads
by incubation with one volume of elution buffer (resuspension
buffer supplemented with 50 mM DTT) overnight.
For co-expression of G9a and histone H3, pMALc2X::
G9a1900 and pR976H3CBD were transformed into E.coli
ER 2566 (NEB). Histone H3 was puriﬁed after washing the
chitin beads with 50 mM Tris–HCl, pH 7.8, 1500 mM NaCl,
1mMEDTAand0.01%TritonX-100withaproteaseinhibitor
cocktail (Sigma) and 0.7 mg/ml PMSF and eluted after over-
night incubation with 50 mM DTT as described previously.
Gene construction and purification of maltose-binding
protein (MBP)-G9a fusion protein from E.coli
A G9aFL cDNA insert was released from pEGFPc2::G9a
by restriction digestion with EcoRI and cloned into the
pMALc2X vector. After conﬁrming the correct orientation
of the insert by restriction digestion, the new plasmid was
digested with BamHI and treated with klenow polymerase.
After clean up with a spin column, the vector (now with a
stop codon) was treated with T4 DNA quick ligase and trans-
formed into E.coli BL21DE3 (Invitrogen).
The PCR products for G9aD634 and G9aD775 (PCR pro-
ducts G9a1 and G9a2 were described earlier for pEGFPc2
cloning) and vector pMALc2X were digested with EcoRI
and SalI, puriﬁed with spin columns and ligated. Ligation
mixtures were transformed into E.coli BL21DE3 (Invitrogen)
andthesenewvectorsweredesignatedaspMALc2X::G9a1900
(G9aD634) and pMALc2X::G9a2324 (G9aD775). Bacu-
lovirus expression of the G9aFL is described elsewhere (34).
Overnight cultures of MBP fusion proteins were inoculated
in 1 liter of Rich medium supplemented with 2 g/l glucose
and 100 mg/l ampicillin. After 2–3 h, protein expression
was induced with 0.5 mM IPTG overnight, shaking at
16 C. The cells were resuspended in 20 ml of MBP column
buffer (20 mM Tris–HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA
with a protease inhibitor cocktail and 0.7 mg/ml PMSF). After
sonication and centrifugation, the cleared lysate was loaded
onto the column. The bound amylose resin was washed with
60 volumes of column buffer, and the fusion protein was
eluted by adding 10 ml of MBP elution buffer (column buffer
supplemented with 10 mM Maltose).
To generate G9a point mutants, two sets of PCR primers
were used. The reverse primer in the ﬁrst set contained a SapI
site with a triplet codon for the desired mutation. The forward
primer of the second set contained a SapI site followed by the
complement triplet codon.AfterSapIdigestionbothfragments
were ligated to obtain the desired mutations. All constructs
were conﬁrmed by restriction digestion and sequencing.
The primer sequences used for point mutant constructs are
available upon request.
Histone methyltransferase assay
Histone methyltransferase assays were carried out at 25 C
for 3 min to overnight in duplicate in a total volume of
25 ml. A typical reaction contained S-adenosyl-L-[methyl-
3H]
methionine (AdoMet) (speciﬁc activity 15 Ci/mmol;
Amersham), substrate histone/peptide and enzyme in assay
buffer (50 mM Tris–HCl, pH 9.0, 5 mM MgCl2,4m M
DTT and 7 mg/ml PMSF). For kinetic analysis, 1 nM peptide
with one target lysine is equal to 1 nM methyl group (34). The
efﬁciency of [
3H] DNA measurements was  55% and all
calculations were corrected accordingly. Data obtained were
plotted by regression analysis using the GraphPad PRISM
program version 4b (GraphPad Software Inc.).
To determine the number of methyl groups added in MBP-
G9aD634 catalyzed reactions, 640 nM of enzyme along with
192 mM synthetic peptide substrate CARTAQTARKSTG-
GY(K-e-Biotin) (K4AK9) and 1.0 mM AdoMet was added
in a total reaction volume of 300 ml. At 0, 15, 30 and
120 min intervals, 50 ml of the samples were withdrawn
and 5 ml of triﬂuoro acetic acid (TFA) was added to stop
the reaction. For completion of methylation, the last sample
was incubated overnight (15 h). As a control, G9a enzyme was
heat inactivated for15min at95 Candincubatedwith K4AK9
and 1 mM AdoMet for 15 h. A blank reaction was performed
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performed at 25 C.
Analysis of peptide methylation by mass spectroscopy
The K4AK9 peptide was prepared using FMOC chemistry.
Lysine methylation of K4AK9 was monitored by matrix-
assisted laser desorption/ionization time-of-ﬂight (MALDI-
TOF) mass spectrometry. The samples were prepared by
mixing 1 ml of sample and 3,5-dimethoxy-4-hydroxycinnamic
acid (AHCA) matrix dissolved in 50:50 acetonitrile: water
containing 0.1% TFA and air drying. The spectra were
obtained on an Applied Biosystems Voyager DE MALDI-
TOF mass spectrometry instrument.
Cell culture and siRNA-mediated knockdown of G9a
HeLa cells (ATCC) were grown in DMEM media with 10%
serum (GIBCO) and transfected with 20 nM of ﬂuorescein-
siRNA transfection control (non-speciﬁc siRNA; NEB) or
siRNA speciﬁc for G9a (si-G9a) using siRNA transfection
reagent Lipofectamine 2000 (Invitrogen). The double-
stranded RNA was made using HiScribe RNAi transcription
kit (NEB) and siRNA mixes were produced using ShortCut
siRNA kit (NEB). The double-stranded RNA was based on
GenBank accession no. bc020970.gb_pr and the fragment
spanned from 590 and 1000 nt.
Western blot analysis of cell extracts was performed with
anti-actin (Sigma), anti-G9a (NEB), anti-H3 (CST), anti-di or
tri-methyl H3-K9 and di-methyl H3-K27 (Upstate) antibodies
according to the manufacturer’s recommendations.
RESULTS
N-terminus of G9a participates in nuclear localization
FunctionalcharacterizationofdifferentdomainsofmouseG9a
was performed with deletion mutants from either the 50 or the
30 regionofthegene.Thesemutantswere clonedin-framewith
GFP as shown in Figure 1A, resulting in green ﬂuorescent
protein(GFP)fusionconstructs.Beforecytochemicalanalysis,
all the fusion constructs were transfected into COS-7 cells,
the extracts were separated on SDS–PAGE gels, western blot-
ted and probed with monoclonal anti-GFP antibodies. All the
constructs expressed fusion proteins of the expected sizes. A
representative panel for some of the expression construct
fusion proteins is shown (Figure 1B). GFP fusion constructs
transfected into COS-7 and HeLa cells were used to identify
amino acidsresponsible fornuclearlocalizationand chromatin
binding. Full-length GFP-G9a fusion proteins localized
exclusively in the nucleus and were clearly enriched at speciﬁc
regions as evidenced by punctate staining patterns. G9a
enzymes were excluded in some cells from nucleoli, the
site of ribosome synthesis. However, a small proportion of
GFP-G9a fusion proteins were also found in nucleoli (data
not shown). A majority of GFP-G9a fusion proteins were
found in pericentric heterochromatin, as observed by complete
overlap of nuclear staining with GFP ﬂuorescence patterns.
Pericentric heterochromatin is transcriptionally silent and the
presence of G9a may facilitate gene repression. Gradual dele-
tions from the G9a C-terminus were performed to determine
the region(s) necessary for nuclear import and heterochro-
matin localization. Deletion of 75 C-terminus amino acids
(G9a3) did not impact the co-localization of G9a in hetero-
chromatin. However, deletion of SET and preSET domains
(G9a4 and G9a5) decreased heterochromatin localization of
the enzyme. Deletion of amino acids 464–598 (G9a6) resulted
in a diffuse nuclear distribution, suggesting the presence of
a heterochromatin-binding sequence. Furthermore, deletion
mutant G9a10, which lacks amino acids 464–598, also local-
ized to heterochromatin, suggesting that a sequence other than
amino acids 464–598 may also be involved in heterochromatic
binding. Several other amino terminus deletions (G9a11, G9a1
and G9a2) were also examined and compared. While G9a11
containing amino acids 109–1263 was transported into the
nucleus and localized on heterochromatin, G9a1 and G9a2
remained cytoplasmic. This is possible if ANK repeats parti-
cipate in heterochromatin binding. Comparing the localization
proﬁles of G9a4, G9a5 and G9a6, we hypothesize that amino
acids between 464 and 890 that includes ANK repeats are
essential for heterochromatin localization in G9a.
Surprisingly, G9a7 expressing amino acids 1–311 and G9a8
expressing amino acids 1–109 of G9a also localize in the
nucleus. Nuclear localization was disrupted in G9a12, which
contains only amino acids 1–24, suggesting a NLS between 24
and 109 in the G9a N-terminus. However, G9a11 that lacks the
ﬁrst 109 amino acids also localizes in the nucleus. This sug-
gests the presence of at least one additional NLS embedded in
the protein. Additional N-terminus deletion mutants represent-
ing amino acids 264–640 (G9a12a), 383–640 (G9a13), 394–
640 (G9a14) and 416–640 (G9a15) were evaluated. Fusion
proteins G9a12a, G9a13 and G9a14 were nuclear localized
(data not shown for G9a12a and G9a13) but G9a15 was
excluded from the nucleus, indicating a second NLS between
amino acids 394 and 416. This region contains two amino acid
stretches that are rich in basic lysine and arginine residues
(392–398, RRKAKKK and 409–415, RKRRKR) that have
been shown to act as NLSs. Thus, murine G9a contains
at least two NLS sequences at the N-terminus of the long
G9a isoform, with the second NLS conserved between both
long and short isoforms of the enzyme in human and mouse
(Figure 1D).
Mutational analysis of conserved NLS
Since G9a translocates to the nucleus to methylate H3-K9,
we devised a strategy to determine the amino acids in the
Figure1. DissectionofnuclearlocalizationsignalsofmurineG9a.(A)AschematicdiagramrepresentingdifferentGFPfusionproteinsusedtodetermineNLS.GFP
is fused at the amino terminus of each fragment. Poly E (En), ANK repeats, preSET and SET domains are indicated. Amino acid residues are indicated below each
construct. Nomenclature for the constructs is indicated on the left. The effects of deletions are summarized at the right, Nu (nuclear), Cy (cytoplasmic) and
H (heterochromatic). (B) Western blot analysis of representative constructs from transfected cell extracts. Constructs are indicated on top and fusion proteins are
markedbyanarrow.Anti-GFPmonoclonalantibodywasusedtoprobetheblot.(C)CytochemicaldetectionofGFPfusionproteins.Deletionconstructsareindicated
on the left. Nuclear staining is shown in purple, GFP-G9a fusions are in green and merge of both purple and green as light blue. Hoechst stain was used for nuclear
staining.(D)MappingandidentificationofNLSofG9a.BothNLS1andNLS2areshowninred.ThetranslatedproteinsequencewasbasedonthefollowingGenBank
accessionnumbers—murineG9a(mG9a):AB077210.gb_ro,humanlongisoform(hG9a)andshortisoformG9a(shortG9a)areNM_006709andBC020970.gb_pr,
respectively.
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(empty vector) and GFP fusion protein expression plasmids
containing amino acids 394 to the native stop codon (G9a394)
were transfected into cells and examined for nuclear localiza-
tion.Thecontrol GFP constructremained predominatelyin the
cytoplasm and G9a394, containing one putative NLS (amino
acids 394–425), displayed predominantly a nuclear localiza-
tion (data not shown). Furthermore, a GFP fusion construct
containing amino acids 394–415 (G9aNLS2) was localized to
the nucleus, suggesting that these amino acids are indeed
crucial for nuclear localization. In order to functionally dissect
the ﬁrst Lys-Arg-rich region (amino acids 394–401) from the
second (amino acids 409–415), another GFP fusion construct,
G9a409, was transfected into cells. G9a409 remained in
the cytoplasm despite the presence of amino acids 409–415
(Figure 2B), suggesting amino acids 394–401 (KAKKKWRK)
comprises the second, functional NLS of G9a. We further
conﬁrmed this observation by transfecting and localizing a
GFP fusion construct containing only amino acids 409–415
of G9a (G9aNLS-KD) along with an identical construct con-
taining Lys to Ala mutations at amino acids 396, 397 and 398
(G9aNLS-mKD). Indeed, the GFP construct containing the
wild-type amino acids was localized exclusively in the nuc-
leus, whereas the mutant remained in both the nucleus and
cytoplasm. This result conﬁrmed that mutation of amino acids
K396, K397 and K398 disrupted nuclear targeting.
C-terminus of G9a participates in histone methylation
In order to determine the structural organization and role of
the N-terminus of G9a in enzymatic catalysis, full-length G9a
(G9aFL) and two N-terminus deletion mutants (D634 and
D775) were cloned into the baculovirus expression vector
pVIC1, or into the MBP fusion expression vector, pMALc2X.
Mutant D634 and D775 were selected because they contained
either the full or partial ANK repeat that is implicated in
protein–protein interactions. The pVIC construct containing
G9aFL has a C-terminus intein chitin binding domain tag.
The mutants D634 and D775 were cloned to the C-terminus
of MBP and were expressed as fusion proteins. G9aFL
and deletion mutants MBP-G9aD634 and MBP-G9aD775
were expressed and enzymes puriﬁed to >90% homogeneity
(Figure 3A). Catalytic activity, as determined by methyl group
transfer, of both wild-type and MBP-G9aD634 on a synthetic
H3 tail (Wt-H3) was similar. MBP-G9aD775 was less active
compared with either the wild-type or MBP-G9aD634 enzyme
(Figure 3B). Thus, we chose MBP-G9aD634 to perform addi-
tional enzymatic studies. All the dialyzed, puriﬁed proteins
(wt, MBP-G9aD634 and MBP-G9aD775) were stored at
 20 C and remained catalytically active for 6 months with
minimal loss of activity.
To determine the functional role of the N-terminus region of
the recombinant G9a in catalysis, steady-state kinetic proper-
ties between wild-type G9aFL and MBP-G9aD634 were com-
pared. The time course for methylation of H3 at constant
enzyme and variable histone H3 concentrations was measured.
The reaction was linear for the ﬁrst 10 min (data not shown),
with each enzyme molecule potentially adding one, two or
three methyl group(s) to lysine during this time. Analysis of
the optimal enzyme and substrate concentrations for this
assessment was described previously (34). Various amounts
ofrecombinant H3 with G9aFL or MBP-G9aD634 were incub-
ated with excess tritiated AdoMet, and the radioactive methyl
group incorporation was measured and plotted against the
substrate concentration. A Michaelis–Menten plot for the
data was generated by nonlinear least-square ﬁt of the data
using an equation for a hyperbolic curve. A representative
Michaelis–Menten plot for MBP-G9aD634 on recombinant
histone H3 substrate is shown in Figure 3C. Similar graphs
were plotted with additional substrates and estimates for Vmax
and Km were determined for the MBP-G9aD634 mutant. The
kcat and catalytic efﬁciency were calculated and compared
with G9aFL as presented in Table 1. In general, N-terminus
deletion mutant MBP-G9aD634 displayed reduced turnover
numbers for all four substrates examined compared with
G9aFL. The Michaelis constant for AdoMet remained similar
for both full-length and deletion mutants, suggesting that
the N-terminus of G9a is not essential for AdoMet binding.
However, the Michaelis constant for substrate peptides and
rH3 were reduced except with K4AK9 substrates. These res-
ults suggest that the N-terminus of G9a may play a role in
substrate recognition and binding, although similar catalytic
Figure 2. Detailed mapping of the second NLS in G9a. (A) Amino acids
sequence comparison of the putative second NLS between mouse and human
G9a. Lys and Arg are shown in red. Lys- and Arg-rich blocks are shown as
I and II. (B) Mutationalanalysis of the second NLS in G9a. Upper panel shows
different constructs used for transfection along with nomenclature at the left
and localization results after transfection at the right. Nu is nuclear and Cy
is cytoplasmic localization of the fusion proteins. Bottom panel shows cells
visualized for GFP fusion proteins in green, nucleus in purple and merge as
whitish blue in the bottom row. Transfected constructs are indicated on top of
the panel.
3216 Nucleic Acids Research, 2005, Vol. 33, No. 10Figure 3. Catalytically active recombinant G9a and its amino terminus deletion mutants (A) Purified G9a full-length (G9aFL) along with amino terminus deletion
mutants MBP-G9aD634 and MBP-G9aD775 resolved on SDS–PAGE. Molecular masses of the markers are indicated on the left. (B) Amino terminus deletion
mutants and G9aFL are capable of histone methylation. Equimolar amounts of enzymes were used in this assay. The background value is deducted from the
experimentalresult.(C)RepresentativeinitialsubstratevelocitycurveforMBP-G9aD634versussubstrateconcentration.MBP-G9aD634activitywithrecombinant
full-lengthhistoneH3substrateisshown.Methylationreactionswereperformedwithsubstrateconcentrationsof0.03,0.033,0.0375,0.05,0.06,0.075,0.1,0.15,0.3,
0.44 and 0.55 mM and fixed enzyme and AdoMet concentrations of 25 nM and 5 mM, respectively. Product formation is plotted versus substrate concentration and
nonlinear regression was performed for the determination of Km values. The inset shows the Lineweaver–Burke plot of the substrate velocity. Vmax and Km were
calculated from the substrate velocity plot. (D) Purified wild-type H3 and point mutants shown in a Coomassie-stained denaturing gel on top panel. Histone
methylation catalyzed by full-length baculovirus expressed G9a. The substrates were purified histones with different point mutations as indicated at the bottom.
Background values were deducted and each bar represents two duplicates. (E) A similar assay as in (C), but the enzyme is MBP-G9aD634.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3217efﬁciencies were observed for both full-length and mutant
enzymes.
We further investigated whether N-terminus deletions con-
tribute to different substrate speciﬁcities. G9a is responsible
for K9 and K27 methylation of histone H3 tails in vitro (21).
The tail of histone H3 also has a lysine at K4 that is methylated
or acetylated. Thus, we mutated K4, K9 and K27 of the histone
H3 tail in various combinations and expressed recombinant
H3 as intein fusion proteins. These fusions were cleaved on
afﬁnity columns with 50 mM DTT and stored with 50% gly-
cerol without any apparent degradation for 6 months. Wild-
type human H3 K4, K9 and K27 mutants (H3-K4A, H3-K9A,
H3-K27A, H3-K4AK9A and H3-K4AK9AK27A) were sep-
aratedonSDSgelsandwere>90%pure(Figure3D,toppanel).
These recombinant H3 and mutant proteins were in vitro
methylated using both G9aFL and MBP-G9aD634 (Figure 3D
and E). As expected, mutant H3-K4AK9A, H3-K9AK27A
and H3-K4AK9AK27Adidnotyield anytritiumincorporation
by either of the enzymes. However, H3 wild-type and
H3-K4A were methylated to various extents. A mutation of
K9A impaired the enzymatic methylation of the substrate
(Figure 3D and E). Surprisingly, the K4A mutation also
impaired the activity of the enzyme. The same set of experi-
ments was conducted with G9a N-terminus mutant G9aD775
and a similar substrate methylation proﬁle was observed
(data not shown). Thus, amino acids 634 and 775 of the
G9a N-terminus are redundant for catalytic functioning of
the enzyme in vitro.
Lysine tri-methylation catalyzed by recombinant G9a
deletion mutant in a processive manner
The epsilon amino group of lysine residues is prone to
methylation. Biochemically, three methyl groups were
added by the recombinant G9aFL histone methyltransferase
(34).ToelucidatethefunctionoftheN-terminusregionofG9a
in the methylation reaction and to determine the number
of methyl groups transferred by deletion mutants of G9a,
MALDI-TOF mass spectroscopy was used. A synthetic H3
peptide was in vitro methylated for different time intervals
with cold AdoMet substrate. The molecular mass of the
peptide was 2038 Da. Because one methyl group is 14 Da,
a mono-, di- or tri-methylation will add 14, 28 or 42 Da onto
the peptide substrate when enzymatic methylation
occurs. Recombinant G9a lacking the ﬁrst 633 amino acids
methylated synthetic peptide in a time-dependent manner by
transferring one methyl group at a time until all the available
lysine residues were mono-methylated (molecular mass 2052).
Once the peptides were converted to mono-methyl K9
peptides, a second methyl group was added until all the
mono-methylated peptides were converted to di-methyl K9
(molecular mass 2066). Prolonged incubation (15 h) of the
enzyme with the substrate converted di-methylated K9 to tri-
methylated K9 peptides (molecular mass 2080) as shown in
Figure 4, panels A–F. Incubation of G9a and synthetic H3
peptide without AdoMet for 15 h did not methylate the sub-
strate peptide, suggesting that the reaction is AdoMet depend-
ent. To differentiate between enzymatic and non-enzymatic
methylation, heat-inactivated G9a was incubated with Ado-
Met and H3 peptide for 15 h followed by mass spectroscopic
analysis. Indeed, there was no methyl group incorporation on
the H3 peptide (Figure 4G). A blank incubation of AdoMet
and peptide also gave similar result (data not shown), conﬁrm-
ing the tri-methylation of K9 is enzymatic. Mutant G9aD634
yielded the same pattern of peptide methylation as that
observed for G9aFL (34). These kinetic data suggest that
both G9aFL and N-terminus-deleted G9a remained efﬁcient
in processive mono-, di- and tri-methylation reactions target-
ing methylation to the K9 residue of histone H3 tails (Figure 4
and data not shown).
G9a is capable of lysine tri-methylation in vivo
WefurtherexaminedwhetherG9acanperformtri-methylation
of lysine 9 in histone H3 in vivo. In the ﬁrst set of experiments,
an overexpressing plasmid clone containing MBP-G9aD634
was transformed along with an H3 overexpression clone
into E.coli. Because E.coli does not possess histones and his-
tone methyltransferases, it provides a unique system to study
methylation reactions catalyzed by G9a in vivo in contrast to
mammalian and insect cell systems. G9a enzymes co-puriﬁed
with H3 even with 1.5 M NaCl washes, suggesting that the
enzyme–substrate complex is strong (Figure 4H, top two pan-
els). Western blot analysis was performed to determine the
methylation status of H3 molecules. Indeed, both anti-K9
di-methyl and tri-methyl speciﬁc antibodies recognized the
histone pool (Figure 4H, bottom two panels), suggesting
that G9a performs di- and tri-methylation in vivo.
Furthermore, we also used siRNA-mediated G9a knock-
down in HeLa cells to determine the status of global H3-K9
tri-methylation. Although a non-speciﬁc siRNA did not reduce
G9a enzyme and H3-K9 tri-methylation levels, a G9a-speciﬁc
siRNA (si-G9a) reduced the level of H3-K9 di- and tri-
methylation (Figure 4I) up to 25 and 40%, respectively,
Table 1. Comparison of steady-state kinetic parameters of recombinant G9aFL and MBP-G9aD634 on various substrates
Substrates Enzyme kcat (h
 1) km
AdoMet (mM) km
pep (mM) kcat/km
pep (10
6 · M
 1 · h
 1) Reference
Wt-H3 G9aFL 88 – 4 1.8 – 0.2 0.9 – 0.1 98 (34)
G9aD634 24 – 1.4 2.3 – 0.2 0.3 – 0.05 80 Present work
rH3 G9aFL 46 – 1 2.65 – 0.2 0.3 – 0.05 153 (34)
G9aD634 19 – 1 2.3 – 0.2 0.2 – 0.02 95 Present work
K4AK9 G9aFL 32 – 2 0.6 – 0.1 1 – 0.1 32 (34)
G9aD634 27 – 21 – 0.2 27 Present work
Wt-H3 (K9dm) G9aFL 12 – 3 2.3 – 1.1 5.2 (34)
G9aD634 5 – 0.4 0.7 – 0.2 7 Present work
Peptide nomenclature is presented under ‘Materials and Methods’ Wt-H3 indicates the first 19 amino acids of the N-terminus of H3. Wt-H3(K9dm) is the
di-methylated Lys9 peptide. Recombinant bacterial-expressed human H3 is shown as rH3.
3218 Nucleic Acids Research, 2005, Vol. 33, No. 10Figure 4. Mass spectroscopic determination of methylation reaction progression by recombinant MBP-G9aD634 (panels A–F). Spectra were taken at time (A)0 ,
(B) 15 min, (C) 30 min, (D) 120 min,(E) 8h and(F) 15 h. Percentageintensityis shownatthe left side andmass(m/z) on the bottom.Singlemethylgroupasmono,
double methyl groups as di and triple methyl groups as tri indicated on top of each peak with respective molecular masses of 2052 (mono), 2066 (di) and 2080 (tri)
daltons. (G) Control experiment with a heat-inactivated enzyme is shown. (H) Western blot analysis of methylation status of lysine 9 histone H3 coexpressed in
the presence of MBP-G9aD634 in E.coli. H3 alone or H3 plus MBP-G9aD634 as indicated on top were expressed. Top two panels show Coomassie staining of the
co-elutedMBP-G9aD634 and H3as well as the gradientof H3 loading.The bottompanelsare westernblot analysisof H3 as indicated under each panel for specific
antibody. (I) siRNA-mediated knockdown of G9a resulted in the reduction of global di- and tri-methylated H3-K9 but not di-methylated H3-K27. siRNAs used for
knockdown are indicated on top and antibodies for each panel on the bottom. Molecular mass is indicated as kDa. Densitometric scan of methylated histones is
shown on the right.
Nucleic Acids Research, 2005, Vol. 33, No. 10 3219as determined by densitometry. Neither of the siRNAs had
any effect on the level of other known H3-K9 tri-methylases,
Suv39H1 (Figure 4I) or on di-methylated H3-K27. These data
conﬁrm that reduction of G9a alone is sufﬁcient to reduce
H3-K9 di- and tri-methylation.
Mutational analysis of conserved G9a C-terminus
amino acid residues
Both G9a and SUV39H histone methyltransferase families
may tri-methylate K9 residues in histone H3 tails. However,
there is little amino acid similarity between these methyltrans-
ferase families, except within the SET and post-SET regions
(Figure 5A). Recent structural analysis of DIM-5, a SUV39H
family H3-K9 methyltransferase from Neurospora crassa,
demonstrates the involvement of SET domain conserved
amino acids R155, W161, Y204 and R234 in forming a
concave pocket (35). This concave pocket is large and can
accommodate more than one cofactor, suggesting that this
pocket may participate in the exchange of the reaction pro-
ducts AdoMet and AdoHcy, thereby facilitating a processive
methylation reaction on H3-K9. A comparison of the primary
Figure 5. Mutation of the conserved amino acids in the SET domain abolishes catalytic activity of G9a. (A) Sequence comparison between the Lys9 trimethylase
DIM-5ofN.crassaandmouseG9aasindicated.Aminoacidsusedforpointmutationanalysisareunderlined.Cysresiduesshowningrayparticipateinmetalbinding
in DIM-5 and are conserved in mouseG9a. The histone methyltransferase signature motifNHXCDPNis shaded. (B) Purified mutants resolvedon SDS–PAGE and
stainedare shown.Mutantsare similarto MBP-G9aD634,except mutation ofindicatedaminoacids is indicatedon top.(C) Methylationof wild-type H3peptideby
purified recombinant wt (MBP-G9aD634) and mutants. Enzymes used for methylation are shown at the bottom. (D) Tritiated AdoMet binding by recombinant
purified mutant G9a as compared with wild-type (MBP-G9aD634) enzyme with the same set of point mutation as that of (C). All experiments were performed in
duplicate and the background values were deducted from experimental values.
3220 Nucleic Acids Research, 2005, Vol. 33, No. 10structure between DIM-5 and G9a revealed identical amino
acids at R1097, W1103, Y1138 and R1162 at the C-terminus
region of these enzymes (Figure 5A). Thus, we determined
whether any of these amino acids is involved in the G9a
methyltransfer reaction. Point mutants using the MBP-
G9aD634 back bone were made and proteins puriﬁed >90%
(Figure 5B). Alanine-substituted point mutation of any of
these conserved amino acids (R1097A, W1103A, Y1138A
and R1162A) rendered the enzyme catalytically inactive
(Figure 5C). We further examined whether these mutations
affected cofactor AdoMet binding in the active site pocket by
titrating tritiated AdoMet binding with puriﬁed G9a enzyme in
solution. A saturating concentration of AdoMet ( 2· Km) was
chosenforstudy.Indeed,thewild-typeenzymeboundstrongly
to AdoMet. However, an  40% decrease in AdoMet binding
was observed in catalytically inactive mutants R1097A,
W1103A, Y1138A and R1162A (Figure 5D), suggesting
that AdoMet binding is compromised in these mutants.
DISCUSSION
G9a possesses a SET domain ﬂanked by cysteine residues,
which is the characteristic of all the histone methyltrans-
ferases. Two isoforms of G9a, 140 and 165 kDa, respectively,
have been identiﬁed in mice by western blot analysis (25).
In addition to the elements present in the human long G9a
isoform, the mouse long isoform contains 53 more residues at
its N-terminus. These additional amino acids in the mouse
long G9a isoform have eight GR (Gly-Arg) repeats. GR motifs
are involved in the nuclear accumulation of the large ﬁbroblast
growth factor isoform (36) and are present in hnRNA binding
proteins (37) and nucleolin (38). Molecular analysis of the
GR motifs in nucleolin suggests that this sequence functions
as a nuclear retention signal (NRS). Our data suggest that GR
repeats in murine G9a function as an NLS, since a GFP fusion
construct with the ﬁrst 100 G9a amino acids localized the
GFP-G9a fusion protein to the nucleus. Mouse GFP-G9a
fusion constructs with amino acids 409–1263 (G9a409) or
634–1263 (G9a1) showed cytoplasmic localization, although
a deletion enzyme with identical amino acid residues was
catalyticallyactive,suggestingthatNLSandcatalyticdomains
are separable. Fine deletion analysis of the G9a N-terminus
region revealed at least two NLS regions, with one between
amino acids 24 and 109 and the other between 394 and 402.
The second NLS is conserved between human and mouse and
is common to both the long and short G9a isoforms. Thus, the
GR repeat-containing long G9a isoform may have specialized
functions that are yet to be discovered. Overall, mouse G9a
appears to have at least three functional regions, including an
N-terminus NLS, central ANK repeats for protein–protein
interactions and a catalytic region at the C-terminus. Archi-
tecturally, the functional organization between G9a and other
DNA (cytosine-5) methyltransferases, such as DNMT1,
DNMT3a and DNMT3b, are similar with an NLS at the
N-terminus region of the protein (39,40). The structural and
functional relevance of the G9a poly-Glu residues is not yet
determined. Furthermore, most of the fusion proteins tested
here localized in both transcriptionally active euchromatin and
transcriptionally inactive heterochromatin. Heterochromatin
is the major location for tri-methylated H3-K9. G9a fusion
proteins containing the ﬁrst 698 amino acids, although
catalytically inactive, were localized on euchromatic and
heterochromatic regions in the nucleus.
G9aFL-MBP fusion or G9a N-terminus deletion fusion
proteins (634 and 775) resulted in catalytically active H3-
speciﬁc methyltransferases. Tachibana et al. (21) had a similar
observation with a 621 amino acid deletion mutant of G9a.
These results suggest that the catalytic domain is functionally
independent of the rest of the protein. Steady-state kinetic
analysis of G9aFL and mutant G9aD634 showed similar
catalytic efﬁciencies, although 3-fold less substrate turnover
and differing Michaelis constants were statistically signiﬁcant.
A similar observation has been noted for the Drosophila
SU(VAR)3-9 histone methyltransferase (41). Thus, the pos-
sibility of N-terminus involvement in substrate binding or
recruitment for catalysis is not excluded in our analysis.
Alternatively, deletion of the N-terminus may affect protein
stability or folding. In contrast to the histone methyl-
transferases G9a and SU(VAR)3-9, deletion of the ﬁrst 580
amino acids in human (cytosine-5) DNA methyltransferase 1
resulted in catalytic activation (42) without changing the
enzyme speciﬁcity to hemi-methylated DNA (43). Both
G9aD634 and G9aD775 mutants were able to methylate
their natural H3 substrates, and peptides mimicking the
N-terminal tail of H3, conﬁrming only the C-terminus is
required for histone methylation, although the N-terminus
inﬂuences the catalytic parameters.
We determined that recombinant G9aFL (34) or the mutant
lacking the ﬁrst 633 amino acids is capable of mono-, di- or
tri-methylation of the target lysine residue by both mass spec-
troscopy analysis and sequencing of the methylated peptide.
In our assay conditions, we were able to tri-methylate all of the
unmethylated substrate (Figure 4). This observation is in con-
trast with studies describing G9a as a H3-K9-speciﬁc mono-
or di-methyltransferase in vivo by deleting G9a (44,45).
However, Suv39h1 deletion showed a small amount of H3
tri-methylation, which is consistent with our observations.
Since most pericentric heterochromatin is tri-methylated by
Suv39H1 and a proportion of euchromatic genes are silenced
by G9a mediated H3 methylation, the small amount of H3-K9
tri-methylation observed in Suv39h1 null cells might be
maintained by G9a. However, associations with additional
H3-K9-speciﬁc methyltransferases are not excluded by
these studies.
In DIM-5, the hydroxyl group of a proximal tyrosine resi-
due (Y178) forms a hydrogen bond with target lysine 9 and
remains highly deprotonated at pH  10. The deprotonation of
Y178 facilitates the deprotonation of the amino group of K9,
resulting in a nucleophilic attack on the positively charged
AdoMet methylsulfonium. The corresponding amino acid
residue in G9a is Y1120. Mutation of Y1120A resulted in a
90% reduction in catalytic activity (data not shown), although
AdoMet binding was not impaired. This observation suggests
an essential role for Y1120 in catalysis, as observed for Y178
in DIM-5. Three conserved cysteines are embedded in the
post-SET region of SETDB1, DIM-5 and SUV39 histone
methyltransferases that are essential for histone lysine methyl-
transferase activity (15,26,35). Zhang et al. (31) proposed that
these three Cys residues coupled with a fourth Cys situated at
the active site pocket (signature motif HXCXPN) form a metal
binding pocket. Indeed, in DIM-5 these residues participate in
Nucleic Acids Research, 2005, Vol. 33, No. 10 3221coordinated Zn
+2 binding. Furthermore, the post-SET and
active site regions are highly conserved between SET
domain-containing proteins, and the metal-binding center is
essential for enzymatic activity. To understand the functional
association of Cys residues in the signature motif (HXCDPN)
of G9a, we mutated C1168A. The mutant enzyme was cata-
lytically inactive, although it can bind AdoMet, conﬁrming
that C1168 and an intact metal-binding pocket are essential for
catalysis (data not shown).
Mutational analysis of the conserved amino acids in the
SET domain of G9a resulted in catalytically inactive
(R1097A,W1103A,Y1138AandR1162A)orreducedactivity
(Y1120A) enzymes.These amino acidsare conserved between
N.crassa DIM-5 histone H3 lysine methyltransferase and G9a.
In DIM-5, mutation of R155H, W161F, Y204F and R238H
reduced the enzymatic activity from 75% to nearly inactive.
The reduced activity in DIM-5 generally mirrored reduced
AdoMet binding. A small reduction in AdoMet binding was
also observed in G9a mutants (R1097A, W1103A, Y1138A
and R1162A), but this did not mirror the enzymatic activity,
suggesting that AdoMet docking into the enzyme for G9a
and DIM-5 may not be similar. However, it is possible that
AdoMet movement in G9a, like DIM-5, may permit exchange
of the reaction product AdoHcy with AdoMet without
releasing the histone tail. This would allow the methyltransfer
reaction to proceed in a processive manner to tri-methylation.
However,the invivomechanism ofG9a-mediatedmethylation
may be regulated by different signaling properties or protein
factors that remain to be deﬁned.
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